Daxor Corporation (
NASDAQ:DXR -
Get Free Report) traded up 7.6% during mid-day trading on Monday . The stock traded as high as $13.00 and last traded at $12.96. 12,411 shares traded hands during trading, an increase of 203% from the average session volume of 4,094 shares. The stock had previously closed at $12.05.
Daxor Stock Performance
The company has a 50-day simple moving average of $10.87 and a 200-day simple moving average of $9.22.
Hedge Funds Weigh In On Daxor
An institutional investor recently bought a new position in Daxor stock. Osaic Holdings Inc. bought a new position in shares of Daxor Corporation (NASDAQ:DXR - Free Report) during the 2nd quarter, according to the company in its most recent filing with the SEC. The fund bought 8,750 shares of the company's stock, valued at approximately $86,000. Osaic Holdings Inc. owned 0.18% of Daxor at the end of the most recent quarter. Hedge funds and other institutional investors own 1.34% of the company's stock.
Daxor Company Profile
(
Get Free Report)
Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Daxor, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Daxor wasn't on the list.
While Daxor currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
